ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1683

Malondialdehyde-Acetaldehyde (MAA) Modified Matrix Gla Protein (MGP) Increases Citrullination by Human Macrophages

Spencer Jones1, nozima Aripova1, Michael Duryee1, Austin Ragland1, Bryant England1, Ted Mikuls2 and Geoffrey Thiele1, 1University of Nebraska Medical Center, Omaha, NE, 2Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2022

Keywords: citrullination, Gene Expression, immunology, Inflammation, macrophages

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Innate Immunity Poster: Basic and Translational Science

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Malondialdehyde and acetaldehyde, by-products of lipid peroxidation, react with free amino groups on proteins to form a stable post-translational modification (PTM), termed MAA. MAA modifications and associated anti-MAA antibodies have been implicated in the pathogenesis of rheumatoid arthritis (RA). In RA synovium, MAA adducts have been shown to co-localize with another PTM, citrullination. Citrullination is mediated by the calcium-dependent enzyme peptidyl arginine deiminase (PAD), and its activity is dependent on tightly regulated intracellular calcium concentrations. One such intracellular calcium regulator is matrix gla protein (MGP), which functions as an intracellular calcium scavenger. The goal of this study was to evaluate potential changes in PAD expression and citrullination that may occur as a result of MAA modification of MGP.

Methods: A human monocytic cell line (U-937) was differentiated to a macrophage phenotype using phorbol 12-myristate 13-acetate (PMA), and subsequently stimulated for 6.5, 24, and 48 hours with either; native MGP or MAA-modified MGP (MGP-MAA). RT-PCR was performed for the following calcium modulators: inositol 1,4,5-Trisphosphate Receptor Interacting Protein (ITPRIPL), calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2), PAD2, and PAD4. Additionally, antigen-stimulated U-937 cells were lysed for protein purification and analyzed using Western Blotting for citrullinated (CIT) proteins using an anti-CIT antibody. The relative expression of protein quantity was normalized to β-actin (endogenous control).

Results: In comparison to native MGP, differentiated U-937 cells stimulated with MGP-MAA demonstrated an increase in mRNA expression for ITPRIPL (2.5-fold, p< 0.001) at 6.5 hours, PAD2 (3.4-fold, p< 0.001) at 48 hours, and PAD4 (5-fold, p< 0.001) at both 24 and 48h (Table 1). For Western Blot, MGP-MAA stimulated cells showed a 10-fold increase (p< 0.001) in citrullinated proteins compared to native MGP stimulated cells with the most prominent band identified at 75 kDA, which is suspected to be PAD2 based on preliminary data (Figure 1).

Conclusion: Although mechanisms underpinning these observations need to be elucidated, these studies suggest that MAA adduction of MGP likely diminishes its function as a calcium scavenger, resulting in an upregulation of key cellular calcium binding proteins. Amongst them is the calcium-dependent enzyme PAD2 and PAD4, which catalyzes the citrullination of proteins. The identification of a prominent 75 kDA band (a molecular weight corresponding to PAD) suggests the possibility that stimulation of cells with MAA-modified MGP may lead to the auto-citrullination of PAD. Taken together, these findings provide insight into a potential mechanism by which increased levels of citrullinated proteins in macrophages are produced resulting in the formation of autoantigens and autoantibodies unique to RA.

Supporting image 1

Table 1. RT-PCR from Stimulated U937 cells. U937 cells were stimulated with either native MGP or MAA adducted MGP (MGP-MAA). Cells were stimulated for 6.5, 24, or 48 hours before RNA collection and cDNA transformation. Primers for inositol 1,4,5-Trisphosphate Receptor Interacting Protein (ITPRIPL), calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2), PAD2, and PAD4 were utilized. All values from MGP-MAA stimulation were compared to MGP stimulation and expressed as relative quantification (RQ) (*p<0.001, #p<0.05).

Supporting image 2

Figure 1. Western Blot from Stimulated U937 cells. U937 cells were stimulated with either native MGP or MAA adducted MGP (MGP-MAA). Cell lysates were probed with (A) anti-citrulline and anti-β-actin antibodies. Densitometry of normalized values to β-actin of (B) 75 kDa citrullination band for CIT, which is suspected to be PAD_2 based off preliminary data. All values from MGP-MAA stimulation were compared to MGP stimulation (*p<0.001, #p<0.05).


Disclosures: S. Jones, None; n. Aripova, None; M. Duryee, None; A. Ragland, None; B. England, Boehringer-Ingelheim; T. Mikuls, Gilead Sciences, Bristol-Myers Squibb, Horizon, Sanofi, Pfizer Inc; G. Thiele, None.

To cite this abstract in AMA style:

Jones S, Aripova n, Duryee M, Ragland A, England B, Mikuls T, Thiele G. Malondialdehyde-Acetaldehyde (MAA) Modified Matrix Gla Protein (MGP) Increases Citrullination by Human Macrophages [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/malondialdehyde-acetaldehyde-maa-modified-matrix-gla-protein-mgp-increases-citrullination-by-human-macrophages/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/malondialdehyde-acetaldehyde-maa-modified-matrix-gla-protein-mgp-increases-citrullination-by-human-macrophages/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology